Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin's lymphoma

被引:3
|
作者
Kamal, Naglaa M. [1 ,2 ]
El-Saban, Khaled [3 ,4 ]
机构
[1] Cairo Univ, Dept Pediat, Fac Med, Cairo, Egypt
[2] Al Hada Forced Arm Hosp, Taif, Saudi Arabia
[3] Cairo Univ, Dept Nucl Med, Fac Med, Cairo, Egypt
[4] Taif Univ, Dept Med Imaging, Fac Med, Taif, Saudi Arabia
关键词
Positron emission tomography; Fluorodeoxyglucose F18; Child; Hodgkin disease; Prognosis; Survival; POSITRON-EMISSION-TOMOGRAPHY; B-CELL LYMPHOMA; SUV-BASED ASSESSMENT; PROGNOSTIC VALUE; EARLY-INTERIM; CYCLES; FDG-PET; TUMOR RESPONSE; FREE SURVIVAL; CHEMOTHERAPY;
D O I
10.23736/S1824-4785.16.02695-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BACKGROUND: The aim of this study was to assess the prognostic role of interim F-18-FDG-PETICT in children with pediatric Hodgkin's lymphoma (PHL). METHODS: We conducted a prospective analysis of 254 Saudi patients with pathologically proven PHL. They underwent interim F-18-FDG-PET/CT after 2 cycles of ABVD with baseline study. Analysis of interim F-18-FDG-PET/CT was done visually according to the Deauville Score (5-point score) as well as a semi-quantitative analysis using maximum standardized uptake value (SUVmax), average SUV (SUVmean2.5 and SUVmean40). The parameters were calculated as absolute values and as percentages of difference between the initial and the interim hottest residual lesion. Follow-up was done for a period of 2.9 years (range, 0.9 to 5.2 years). Clinical outcomes were obtained from medical records. RESULTS: Two hundred and twenty out of 254 children showed PET-ve interim, while 34 were still PET+ve. Univariate analysis showed that the risk stratification. qualitative analysis of interim F-18-FDG-PET/CT were significant predictors for total actuarial survival (TAS) and disease free survival (DFS). Among the semi-quantitative parameters. ASUVmean2.5 has the highest hazard ratio. In multivariate analysis, the current study revealed that the three above factors were important prognostic factors that can predict TAS and DFS. However, visual assessment of interim PET canceled the prognostic impact of ASUVmean2.5. CONCLUSIONS: Visual assessment of early interim F-18-FDG-PET/CT after 2 cycles of ABVD in PHL showed a very significant role in prediction of TAS and DFS.
引用
收藏
页码:376 / 385
页数:10
相关论文
共 50 条
  • [1] The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma
    Qiu, Lin
    Chen, Yue
    Wu, Jingbo
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2013, 16 (03): : 230 - 236
  • [2] 18F-FDG-PET/CT in the assessment of bone marrow involvement in pediatric Non-Hodgkin lymphoma
    Achituv, Sivan
    Lerman, Hedva
    Even-Sapir, Einat
    Dvir, Rina
    Levin, Dror
    Bitan, Menachem
    Manistarski, Michal
    Rosenfeld-Keidar, Hila
    Elhasid, Ronit
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 31 - 31
  • [3] The Role of 18F-FDG-PET/CT in Pediatric Sarcoma
    Harrison, Douglas J.
    Parisi, Marguerite T.
    Shulkin, Barry L.
    SEMINARS IN NUCLEAR MEDICINE, 2017, 47 (03) : 229 - 241
  • [4] Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma
    Carrillo-Cruz, Estrella
    Marin-Oyaga, Victor A.
    Sole Rodriguez, Maria
    Borrego-Dorado, Isabel
    de la Cruz Vicente, Fatima
    Quiroga Cantero, Eduardo
    Manzanares Perez, Marina
    Capote, Francisco J.
    Ramirez Sanchez, Maria J.
    Espigado Tocino, Ildefonso
    Perez-Vega, Herminia
    Vazquez-Albertino, Ricardo
    Perez-Simon, Jose A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (01) : 23 - 30
  • [5] Role of volumetric analyses on [18F]FDG PET/CT in pediatric Hodgkin lymphoma
    Lopci, Egesta
    Mascarin, Maurizio
    EXPERT REVIEW OF HEMATOLOGY, 2023,
  • [6] Stage IE non-Hodgkin's thyroid lymphoma on 18F-FDG-PET/CT
    Mehta, Amar
    Muthukrishnan, Ashok
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2011, 14 (02): : 186 - 187
  • [7] ROLE OF 18F-FDG-PET/CT IN THE ASSESSMENT OF RESIDUAL DISEASE (RD) AFTER TREATMENT OF HODGKIN LYMPHOMA (HL) IN CHILDREN
    Sana, L.
    Sala, A.
    Guerra, L.
    Locatelli, L.
    Dell'Oro, M. G.
    Di Lelio, A.
    Kirienko, M.
    Mapelli, P.
    Crivellaro, M.
    Isimbaldi, G.
    Meregalli, S.
    Conter, V.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (05) : 881 - 881
  • [8] 18F-FDG-PET/CT IN THE ASSESSMENT OF BONE MARROWINVOLVEMENT IN PEDIATRIC NON-HODGKIN LYMPHOMA- A SINGLE CENTER EXPEREIENCE
    Siri, M.
    Rosenfeld-Keidar, H.
    Yaffe-Ornstein, M.
    Shukrun, R.
    Elhasid, R.
    LEUKEMIA RESEARCH, 2022, 121 : S19 - S20
  • [9] Utility of 18F-FDG-PET/CT for bone assessment in the initial staging of patients diagnosed of Hodgkin's lymphoma.
    Fernandez Rodriguez, M.
    Rodriguez Pelayo, E.
    Castillejos Rodriguez, M. L.
    Sandoval Moreno, C.
    Balsa Breton, M. A.
    Garcia Alonso, M. P.
    Paniagua Correa, C.
    Ortega Valle, A.
    Penin Gonzalez, F. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S686 - S687
  • [10] Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma
    Fox, Thomas A.
    Carpenter, Ben
    Taj, Mary
    Perisoglou, Martha
    Nicholson, Emma
    Castleton, Anna
    Elliot, Johnathon
    Uttenthal, Ben
    Wright, Callum
    Halsey, Richard
    Khwaja, Asim
    Grandage, Victoria
    Mansour, Marc R.
    Fielding, Adele K.
    Hough, Rachael
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 1010 - 1012